0x

guest@0xbase ~$ read-only mode. Posting requires EU location.

Post
Spotlight Jun 09

Featured Spotlight

HIQA RSV Immunisation Cost-Effectiveness and Sláintecare Implementation Challenges

Analysis Briefing

All briefings

7-DAY ROUNDUP

AI-designed vaccine and ERAP1 inhibitor show early promise; HIQA updates disability standards

  1. NIAC Issues Updated Standing COVID-19 Vaccination Recommendations for Ireland (May 2025) (hiqa.ie) | 17d ago
  2. HSE Diabetes Policy and Services Review: A Strategy for Better Care (assets.gov.ie) | 19d ago
  3. IPHA-HSE Framework Agreement on Medicine Pricing 2026-2029 (ipha.ie) | 98d ago
  4. NCPE Recommends Against Reimbursement of Belzutifan (Welireg) for von Hippel-Lindau Disease in Ireland (ncpe.ie) | 15d ago
  5. NCPE Assessment: Belzutifan not cost-effective for VHL disease-associated tumours at current price (ncpe.ie) | 39d ago
  6. NCPE Recommends Belzutifan (Welireg) Not Reimbursed for VHL Disease on Cost-Effectiveness Grounds (ncpe.ie) | 39d ago
  7. HIQA publishes health technology assessment on RSV immunisation in Ireland (hiqa.ie) | 42d ago
  8. HIQA Publishes Draft National Standards for Residential Services for Disabled People for Public Consultation (hiqa.ie) | 8d ago
  9. Official 2024 Sláintecare Progress Report: Key Metrics on Access, Quality, and Capacity (drugsandalcohol.ie) | 14d ago
  10. HIQA Publishes New Framework for Hospital Inpatient Services (youtube.com) | 14d ago
  11. HSE Chief Executive Bernard Gloster Outlines Health System Challenges and Reform Agenda in Interview (youtube.com) | 14d ago
  12. HIQA 2023 HTA Impact Report: Knowledge Sharing and Influence on Irish Health Policy (hiqa.ie) | 17d ago
  13. HIQA Scoping Review: Public Funding for Donor-Assisted Reproduction in International Context (hiqa.ie) | 17d ago
  14. Cancer Trends Report No. 42: Skin Cancer in Ireland (ncri.ie) | 439d ago
  15. Daraxonrasib Phase 3 Trial Shows Doubled Overall Survival in Metastatic Pancreatic Cancer (worksinprogress.co) | 13d ago
  16. FDA approves Guardant Health Shield blood test for colorectal cancer screening in average-risk adults aged 45 and older (accessdata.fda.gov) | 683d ago
  17. FDA approves Shield blood test for colorectal cancer screening in average-risk adults aged 45 and older (accessdata.fda.gov) | 872d ago
  18. HIQA Publishes Health Technology Assessment of RSV Immunisation in Ireland (hiqa.ie) | 42d ago
  19. Rising colorectal cancer incidence in young adults examined (doi.org) | 13d ago
  20. HSE Review of National Women and Infants Health Programme Implementation (data.oireachtas.ie) | 13d ago
  21. Colorectal cancer incidence rising across birth cohorts: analysis shows increase at all ages (dynomight.net) | 14d ago
  22. Analysis of the 2022 Sláintecare Progress Report (medicalindependent.ie) | 14d ago
  23. Sláintecare Implementation in Ireland: Progress and Persistent Challenges (youtube.com) | 14d ago
  24. Study finds limited progress in Sláintecare implementation by 2020 (pmc.ncbi.nlm.nih.gov) | 14d ago
  25. Long-term reliance on migrant nurses in Ireland: findings from a two-decade empirical study (pmc.ncbi.nlm.nih.gov) | 15d ago
  26. Analysis of Neoplasm Adverse Events Associated with GLP-1 Receptor Agonists from FAERS Database (frontiersin.org) | 15d ago
  27. HSE briefing documents reveal scale of challenges for new CEO Anne O'Connor (imt.ie) | 15d ago
  28. Ireland's COVID-19 Spring 2025 Booster Uptake: HPSC Weekly Report (June 2025) (hpsc.ie) | 373d ago
  29. INMO Trolley Watch Data Tracks Hospital Overcrowding in Ireland (inmo.ie) | 17d ago
  30. COVID-19 Spring Booster Uptake in Ireland: HPSC Reports Low Early Uptake Among Over-80s (hpsc.ie) | 17d ago
  31. Sláintecare 2025+: Minister for Health Publishes Updated Universal Healthcare Plan (gov.ie) | 17d ago
  32. Sláintecare 2025+ Plan: Government's 23 Priority Actions for Irish Health Service Reform (imt.ie) | 17d ago
  33. Assessment of Ireland's Health Information System for Health System Performance Evaluation (pmc.ncbi.nlm.nih.gov) | 17d ago
  34. Scoping review: Association between herpes zoster vaccination and dementia risk (hiqa.ie) | 21d ago
  35. HIQA Rapid Health Technology Assessment of RSV Immunisation for Infants and Older Adults in Ireland (hiqa.ie) | 665d ago
  36. HIQA Health Technology Assessment Recommends Shingles Vaccination for Older Adults in Ireland (hiqa.ie) | 690d ago
  37. Oireachtas Q&A on 2026 Waiting Time Action Plan (oireachtas.ie) | 125d ago
  38. HIQA Protocol for Health Technology Assessment of COVID-19 Vaccination in Ireland (hiqa.ie) | 35d ago
  39. Smart drug GRWD5769 shrinks lung cancer tumours by nearly 30% in patient trial (theguardian.com) | 8d ago
  40. HSE requests HIQA cost-benefit assessment on CGM reimbursement for insulin-dependent type 2 diabetes (imt.ie) | 10d ago
  41. HIQA Publishes 28 Inspection Reports on Irish Disability Residential Centres (hiqa.ie) | 12d ago
  42. National Cancer Registry Ireland Report: Skin Cancer Incidence and Trends, 1994-2022 (ncri.ie) | 1256d ago
  43. Phase 1 trial of ERAP1 inhibitor GRWD5769 shows tumor shrinkage in six cancer types when combined with cemiplimab (theguardian.com) | 4d ago
  44. NIAC Updates RSV Vaccination Recommendations for Older Adults in Ireland (hiqa.ie) | 250d ago
  45. Ireland to expand eligibility for state-funded IVF and assisted reproduction treatments from June 2025 (gov.ie) | 15d ago
  46. HRB awards €2.4 million in grants to directly inform health policy (hrb.ie) | 15d ago
  47. GLP-1 Medications May Reduce Cancer Progression, Study Says (huffpost.com) | 16d ago
  48. Minister for Health Releases 2026 Waiting Time Action Plan – NTPF (ntpf.ie) | 17d ago
  49. IHCA FutureCare Report: Action Plan for Health 2026 (ihca.ie) | 17d ago
  50. Rapid Review of Rozanolixizumab (Rystiggo) for gMG Completed by NCPE (ncpe.ie) | 11d ago
Showing page 1 of 5 (203 total results)
← Prev Next →
src: all hn rss osint